But I really feel that SNDK is positioned to be bought out here. Price is very attractive. Maybe QCOM?
QCOM would be a great candidate and they can use some mojo!
by end of next week.
It will gap up huge in the morning.
Bet on it!
1. Lawsuits have no merit. If you read their press published in June, you know the drug is progressing very well as ANTICIPATED. Analysts are right about this. Which brings me to my next point.
2. When PBYI was trading north of $200 it had market cap of $7b, which to me was too high. The valuation now has better chance of getting picked up by someone. I'd say $5B by JNJ.
I've been following this stock over 1.5 years and made lots of money. I am back in.
Mgmt says so!
I think there is news coming
I wouldn't pay any attention to this BS. This country is ruined by all these Curry breathes.
No company will be interested AFTER it gains approval. M&A is transacted prior to the FDA approval. Buy on the rumor, sell it on the news, Got it?